Summary
Human neutrophils, incubated with Cr51-labelled B lymphoblastoid Raji cells in the presence of the anti-target monoclonal antibody (mAb) Lym-1 plus formyl-methionyl-leucyl-phenylalanine (FMLP) or tumour necrosis factor alpha (TNF-α), were found to induce significant Cr51 release, i.e. significant cytolysis. The lytic process was inhibited by mAb IV.3, specific for the Fcγ receptor (FcγR) type II. The mAb 3G8, which reacts with FcγR type III, was ineffective. Moreover, the lysis was inhibited by the anti-CD18 mAb MEM-48. These data suggest that FMLP/Lym-1 as well as TNF-α/Lym-1 cytolytic systems strictly require FcγRII and CD18 integrins. As the lysis induced by TNF-α/Lym-1 was prevented by pertussis toxin (PT), PT-sensitive G-proteins are likely to intervene in post-FcγRII signal transduction. Both the FMLP- and the TNF-α-dependent systems were also found to be equally susceptible to inhibition by various inhibitors of kinases (genistein, staurosporin, 1-(5-isoquinolinnylsulphonyl)-2-methylpiperazine and wortmannin). On the contrary, an inhibitor of protein kinase C (bis-indolyl-maleimide, BIM) was effective only in the FMLP/Lym-1 cytolytic system. Therefore, it appears that signals delivered by FMLP or TNF-α, BIM-sensitive and insensitive respectively, converge and synergize with those from G-protein-coupled FcγRII and, probably, CD18-integrins to promote the expression of the neutrophil cytolytic potential.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Anderson, D. C., Schmalstieg, F. C., Arnaout, M. A., Kohl, S., Tosi, M. F., Dana, N., Buffone, G. J., Hughes, B. J., Brinkely, B. R., Dickey, W. D., Abramson, J. S., Springer, T., Boxer, L. A., Hollers, J. M. & Smith, C. W. (1984). Abnormalities of polymorphonuclear leukocyte function with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to dimished cell adherence. J Clin Invest 74: 536–551.
Baldwin, G. C., Chung, G. Y., Kaslander, C., Esmail, T., Reinsfeld, R. A. & Golde, D. W. (1993). Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity toward neuroectodermal tumour cells. Br J Haematol 83: 545–553.
Buckle, A. M. & Hogg, N. (1989). The effect of IFN-γ and colony-stimulating factors on the expression of neutrophil cell membrane receptors. J Immunol 143: 2295–2301.
Clark, R. A. & Klebanoff, S. J. (1977). Studies on the mechanism of antibody-dependent polymorphonuclear leukocyte-mediated cytoxicity. J Immunol 119: 1413–1418.
Colombo, M. P., Lombardi, L., Stoppacciaro, A., Melani, C., Parenza, M., Bottazzi, B. & Parmiani, G. (1992a). Granulocyte-colony stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. J Immunol 145: 113–119.
Colombo, M. P., Modesti, A., Parmiani, G. & Forni, G. (1992b). Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res 52: 4853–4857.
Dallegri, F., Patrone, F., Frumento, G. & Sacchetti, C. (1984). Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. J Natl Cancer Inst 73: 331–339.
Dinarello, C. A. (1992). Role of interleukin-1 and tumor necrosis factor in systemic responses to infection and inflammation. In Inflammation: Basic Principles and Clinical Correlates, Gallin JI, Goldstein IM and Snyderman R (eds), pp. 211–232. Raven Press Ltd: New York
Elsässer, D., Valerius, T., Repp, R., Weiner, G. J., Deo, Y., Kalden, J. R., van de Winkel, J. G. J., Stevenson, G. T., Glennie, M. J. & Gramatzki, M. (1996). HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor. Blood 87: 3803–3812.
Epstein, A. L., Mader, R. J., Winter, J. N., Stathopoulos, E., Chen, F. M., Parker, J. W. & Taylor, C. R. (1987). Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Cancer Res 47: 830
Fady, C., Reisser, D. & Martin, F. (1990). Non-activated rat neutrophils kill syngeneic colon tumor cell by the release of low molecular weight factor. Immunobiology 181: 1–12.
Feister, A. J., Browder, B., Willis, H. E., Mohanakumar, T. & Ruddy, S. (1988). Pertussis toxin inhibits human neutrophil responses mediated by the 42-kilodalton IgG Fc receptor. J Immunol 141: 228–233.
Flesch, B. K., Achter, G. & Neppert, J. (1997). Inhibition of monocyte and polymorphonuclear granulocyte immune phagocytosis by monoclonal antibodies specific for FcγRI, II and III. Ann Hematol 74: 15–22.
Gale, R. P. & Zighelboim, J. (1974). Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity. J Immunol 113: 1793–1800.
Gavioli, R., Spisani, S., Giuliani, A. L. & Traniello, S. (1990). Dual mechanism in induction of human neutrophil cytotoxicity: activation of protein kinase C and elevation in intracellular calcium. Clin Exp Immunol 80: 247–251.
Gavioli, R., Spisani, S., Giuliani, A. L., Cosulich, E., Risso, A. & Traniello, S. (1991). CD16 and C3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils. Br J Haematol 79: 170–176.
Ginis, I. & Tauber, A. I. (1990). Activation mechanisms of adherent human neutrophils. Blood 76: 1233–1239.
Graziano, R. F. & Fanger, M. W. (1987). FcγRI and FcγRII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J Immunol 139: 3536–3541.
Gresham, H. D., Clement, L. T., Volanakis, J. E. & Brown, E. J. (1987). Cholera toxin and pertussis toxin regulate the Fc receptor-mediated phagocytic response of human neutrophils in a manner analogous to regulation by monoclonal 1C2. J Immunol 139: 4159–4166.
Hamada, F., Aoki, M., Akiyama, T. & Toyoshima, K. (1993). Association of immunoglobulin G Fc receptor II with Src-like protein-tyrosine kinase with Fgr in neutrophils. Proc Natl Acad Sci USA 90: 6305–6309.
Hu, E., Epstein, A. L., Naeve Hu, E., Epstein, A. L., Naeve, G. S., Gill, I., Martin, S., Sherrod, A., Nichols, P., Chen, D., Mazumder, A. & Levine, A. M. (1989). A phase 1a clinical trial of Lym-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies. Hematd Oncol 7: 155–166.
Huizinga, T. W. J., de Haas, M., Kleijer, M., Nuijens, J. H., Roos, D. & van dem Borne, AEGK (1990). Soluble Fcγ receptor III in human plasma originates from release by neutrophils. J Clin Invest 86: 416–423.
Hynes, R. O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11–25.
Kohl, S., Springer, T. A., Schmalstieg, F. C., Loo, L. S. & Anderson, D. C. (1984). Defective natural killer cytotoxicity and polymorphonuclear leukocyte antibody-dependent cellular cytotoxicity in patients with LFA-1/OKM-1 deficiency. J Immunol 133: 2972–2978.
Kushner, B. H. & Cheung, N. K. V. (1989). GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 73: 1936–1941.
Kushner, B. H. & Cheung, N. K. V. (1991). Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes. Cancer Res 51: 4865–4870.
Kushner, B. H. & Cheung, N. K. V. (1992). Absolute requirement of CD11/CD18 adhesion molecules, FcRII, and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity. Blood 79: 1484–1490.
Levy, P. C., Show, G. M. & LoBuglio, A. F. (1979). Human monocyte, lymphocyte, and granulocyte antibody-dependent cell-mediated cytotoxicity toward tumor cells. I. General characteristic of cytolysis. J Immunol 123: 594–599.
Midorikama, Y., Yamashita, T. & Sendo, F. (1990). Modulation of the immune response to transplanted tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody: abrogation of specific transplantation resistance to chemical neutrophils in vivo. Cancer Res 50: 6243–6247.
Nishizuka, Y. (1995). Protein kinase C and lipid signalling for sustained cellular responses. FASEB J 9: 484–496.
Obrist, R., Schmidli, J., Müller, R., Gallati, H. & Obrecht, J. P. (1991). Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial. Cancer Immunol Immunother 32: 406–408.
Ottonello, L., Morone, P., Dapino, P. & Dallegri, F. (1996). Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid targets by human complement and cytokine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes. Blood 87: 5171–5178.
Petty, H. R., Francis, J. W. & Anderson, C. L. (1989). Cell surface distribution of Fc receptors II and III on living human neutrophils before and during antibody dependent cellular cytotoxicity. J Cell Physiol 141: 598–605.
Pickaver, A. H., Ratcliffe, N. A., Williams, A. E. & Smith, H. (1972). Cytotoxic effects of peritoneal neutrophils on a syngeneic rat tumor. Nat New Biol 235: 187–189.
Ranhammar, P., Frödin, J. E., Trotta, P. P. & Mellstedt, H. (1994). Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor and macrophage colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies. Cancer Immunol Immunother 39: 254–262.
Repp, R., Valerius, T., Sendler, A., Gramatki, M., Iro, H., Kalden, J. R. & Platzer, E. (1991). Neutrophils express the high affinity receptor for IgG (FcγRI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 78: 885–889.
Rollet, E., Caon, A. C., Roberge, C. J., Liao, N. W., Malawista, S. E., McColl, S. R. & Naccache, P. H. (1994). Tyrosine phosphorylation in activated neutrophils. Comparison of the effects of different classes of agonists and identification of the signalling pathways involved. J Immunol 153: 353–363.
Snyderman, R. & Uhing, R. J. (1992). Chemoattractant stimulus-response coupling. In Inflammation: Basic Principles and Clinical Correlates, Gallin JI, Goldstein IM and Snyderman R (eds), pp 421–439. Raven Press: New York
Tosi, M. F. & Zackem, H. (1992). Surface expression of Fcγ receptor III (CD16) on chemoattractant-stimulated neutrophils is determine by both surface shedding and translocation from intracellular storage compartments. J Clin Invest 90: 462–470.
Toullec, D., Pianetti, P., Coste, H., Bellevergue, B., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E. & Loriolle, F. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771–15781.
Vaickus, L., Biddle, W., Cemerlic, D. & Foon, K. A. (1990). Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis. Blood 75: 2408–2416.
Valerius, T., Repp, R., de Witt, T. P. M., Berthold, S., Platzer, E., Kalden, J. R., Gramatzki, M. & van de Winkel, J. G. J. (1993). Involvement of the high-affinity receptor for IgG (FcγRI, CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood 82: 931–939.
Valerius, T., Elsässer, D., Repp, R., van de Winkel, J. G. J., Gramatzki, M. & Glennie, M. (1997). HLA class II antibodies recruit G-CSF activated neutrophils for treatment for B cell malignancy. Leukemia Lymphoma 26: 261–269.
Vlahos, C. J., Matter, W. F., Brown, R. F., Traynor-Kaplan, A. E., Heyworth, P. G., Prossnitz, E. R., Ye, R. D., Marder, P., Schelm, J. A., Rothfuss, K. J., Serlin, B. S. & Simpson, P. J. (1995). Investigation of neutrophil signal transduction using specific inhibitor of phosphatidylinositol 3-kinase. J Immunol 154: 2413–2422.
Würflein, D., Dechant, M., Stockmeyer, B., Tutt, A. L., Hu, P., Repp, R., Kalden, J. R., van de Wikel, J. G. J., Epstein, A. L., Valerius, T., Glennie, M. & Gramatzki, M. (1998). Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells. Cancer Res 58: 3051–3058.
Zhou, M., Lublin, D. M., Link, D. C. & Brown, E. J. (1995). Distinct tyrosine kinase activation and triton X-100 insolubility upon FcγRII or FcγRIIIB ligation in human polymorphonuclear leukocytes. Implications for immune complex activation on the respiratory burst. J Biol Chem 270: 13553–13560.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ottonello, L., Morone, P., Mancini, M. et al. FMLP- and TNF-stimulated monoclonal Lym-1 antibody-dependent lysis of B lymphoblastoid tumour targets by neutrophils. Br J Cancer 80, 331–337 (1999). https://doi.org/10.1038/sj.bjc.6690359
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690359
Keywords
This article is cited by
-
Synergistic action of fMLP-boanmycin combination on the growth of mouse colon carcinoma and its action mechanisms
Chinese Journal of Cancer Research (2010)
-
Inducing neutrophil recruitment in the liver of ICAM-1-deficient mice using polyethyleneimine grafted with Pluronic P123 as an organ-specific carrier for transgenic ICAM-1
Gene Therapy (2002)